ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AmerisourceBergen Adds FirstView Financial to its Suite of Manufacturer Solutions

Addition of FirstView positions AmerisourceBergen to meet the increased demand for patient support and healthcare solutions as waves of specialty products enter the market

AmerisourceBergen, a global healthcare company, bolstered its suite of manufacturer solutions through the addition of FirstView Financial (FirstView), a fintech solutions provider that delivers innovative digital payment processing services to support patient affordability and access programs, pharmacy and provider networks, and payors and plan administrators. FirstView enables AmerisourceBergen to provide more robust, integrated services, including an enhanced patient support offering designed to help patients gain access to, afford and stay on vital therapies.

Driven by the burgeoning pipeline of therapies, specialty pharmaceutical products are projected to account for nearly two-thirds of new product launches by 2023. As the number of specialty and rare disease products continues to increase, the demand for patient support services is expected to grow significantly by 2026. AmerisourceBergen adds FirstView’s copay program management and payment processing services to its existing portfolio of patient support and healthcare solutions, creating an enhanced and differentiated market offering that better supports the needs of manufacturers, healthcare providers and patients.

“Our leadership role with specialty product services allows us to continue to make investments to ensure we’re best positioned to help patients access their prescribed therapies,” said Robert Mauch, PhD, Executive Vice President and Group President of AmerisourceBergen. “With FirstView, we’ve broadened our portfolio of manufacturer services by adding tech-driven payment and processing solutions that can reduce barriers throughout the treatment journey. The new solutions, coupled with our existing patient-centric services, enable us to meet the evolving needs of our partners and the patients they serve.”

Founded in 2006, FirstView supports organizations across the pharmaceutical industry—from pharmaceutical manufacturers to hub providers and specialty pharmacies—by delivering seamless payment solutions that help partners manage and execute effective patient support programs. Powered by its omni-channel digital technology platform, ProXe360®, FirstView provides program administration and payment processing services, including real-time copay payments and claims adjudication services. The platform supports a broad range of payment options, including digital and mobile payment capabilities that increase convenience and expedite the payment process. Through its ProXeclaim® adjudication service, FirstView helps manufacturers implement and manage complex claims transactions in closed networks of specialty pharmacies and provides them with flexible solutions that can help patients and pharmacies navigate barriers that affect access.

The new solutions further enhance AmerisourceBergen’s existing suite of manufacturer services that are designed to improve patient access, affordability and adherence throughout the treatment journey. The broad range of services leverage advanced technology solutions to simplify the patient and provider experience, accelerate access to therapy, reduce financial burdens and empower patient engagement.

“In working with healthcare and pharmaceutical companies, our goal has always been to deliver a simple and seamless payment solution that helps to eliminate financial barriers and increase patient access and adherence to the medications they need,” said Bob Raffo, president and CEO of FirstView. “We’re excited to combine our industry leading technology platform with AmerisourceBergen’s portfolio of services and capabilities to expand our reach in the specialty pharmaceutical and provider space and further advance our shared commitment of expanding patient access to critical therapies. As the healthcare landscape evolves, we will continue to adapt our technology platform and introduce new, innovative healthcare-fintech solutions that increase convenience, transparency and control of digital payments and meet the needs of the customers we serve.”

About AmerisourceBergen

AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies and providers, we create unparalleled access, efficiency and reliability for human and animal health. Our 41,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #8 on the Fortune 500 with more than $200 billion in annual revenue. Learn more at www.amerisourcebergen.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.86
+0.00 (0.00%)
AAPL  271.40
+0.00 (0.00%)
AMD  254.84
+0.00 (0.00%)
BAC  53.03
+0.00 (0.00%)
GOOG  281.90
+0.00 (0.00%)
META  666.47
+0.00 (0.00%)
MSFT  525.76
+0.00 (0.00%)
NVDA  202.89
+0.00 (0.00%)
ORCL  256.89
+0.00 (0.00%)
TSLA  440.10
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.